In recent years, artificial intelligence programs for drug design have steadily shown they can help explore far beyond just small-molecule drugs—by illuminating how proteins fold and interact, all the ...
University of Washington professor David Baker has made a name for himself by borrowing computer science concepts like machine learning and artificial intelligence to solve problems in biology. A few ...
The co-lead authors of a study publishing today in Science describing AI-designed proteins for target health theraphies, from left: Julia Bonzanini, Nathan Greenwood and Bingxu Liu. All are ...
De novo enzyme design has been used, primarily, in efforts to introduce active sites and substrate-binding pockets. Now, for the first time, scientists have used machine learning to create brand-new ...
Researchers at the University of Washington have shown that a generative AI program can help draw up atomically accurate antibodies from scratch—including those capable of binding to bacterial toxins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results